Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
CSL Limited and Cochlear Limited: Snap up these top healthcare stocks for 2015
⏸️ Investing
5 US-exposed ASX stocks to buy for 2015
⏸️ Investing
Caltex Australia Limited, Cochlear Limited, Tabcorp Holdings Limited: Should you buy today?
⏸️ Investing
2 big reasons why you should own Cochlear Limited shares
⏸️ Investing
2 top performing stocks that still have room to run hard
⏸️ Investing
Can Cochlear Limited continue to outperform ResMed Inc. (CHESS)?
⏸️ Investing
Will Commonwealth Bank of Australia be the first $100 stock?
⏸️ Investing
Should you get defensive with these 3 big name stocks?
⏸️ Investing
What sell-off? Here's why Cochlear Limited is up while the market slides
⏸️ Investing
Cochlear Limited says China not golden ticket to riches
⏸️ Investing
3 hot healthcare stocks to make your returns healthier
⏸️ Investing
3 companies to profit from a lower Australian dollar
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
